Compoundeer Logo
COMPOUNDEER
Uncovering Potential
RankingCompaniesDCF
ENOV Logo

Enovis Corp

ENOV

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Mkt Cap

$3.285B

PE

-43.90

Debt

$395M

Cash

$32.13M

EV

$3.648B

FCF

-$100.4M

Market Cap

$3.285B

P/E Ratio

-43.90

Debt

$395M

Cash

$32.13M

EV

$3.648B

FCF

-$100.4M
Charts data: {"Earnings":[{"time":"2014-12-30","value":370185000},{"time":"2015-12-30","value":167739000},{"time":"2016-12-30","value":128111000},{"time":"2017-12-30","value":-72957000},{"time":"2018-12-30","value":140196000},{"time":"2019-12-30","value":-527646000},{"time":"2020-12-30","value":42625000},{"time":"2021-12-30","value":71657000},{"time":"2022-12-30","value":-13292000}],"Sales":[{"time":"2014-12-30","value":4624476000},{"time":"2015-12-30","value":3967053000},{"time":"2016-12-30","value":3647047000},{"time":"2017-12-30","value":3300184000},{"time":"2018-12-30","value":3666812000},{"time":"2019-12-30","value":3327458000},{"time":"2020-12-30","value":3070769000},{"time":"2021-12-30","value":3854303000},{"time":"2022-12-30","value":1563101000}],"Net Margins":[{"time":"2014-12-30","value":0.08004906934320775},{"time":"2015-12-30","value":0.04228302470372843},{"time":"2016-12-30","value":0.035127323557936053},{"time":"2017-12-30","value":-0.022106949188287685},{"time":"2018-12-30","value":0.03823375728016599},{"time":"2019-12-30","value":-0.1585733013008729},{"time":"2020-12-30","value":0.013880887816699987},{"time":"2021-12-30","value":0.018591428852376163},{"time":"2022-12-30","value":-0.008503609171768171}],"Assets":[{"time":"2014-12-30","value":7245098000},{"time":"2015-12-30","value":6732919000},{"time":"2016-12-30","value":6385459000},{"time":"2017-12-30","value":6709697000},{"time":"2018-12-30","value":6603872000},{"time":"2019-12-30","value":7386832000},{"time":"2020-12-30","value":7351549000},{"time":"2021-12-30","value":8515345000},{"time":"2022-12-30","value":4273248000}],"Stockholders Equity":[{"time":"2014-12-30","value":3352444000},{"time":"2015-12-30","value":3256556000},{"time":"2016-12-30","value":3093344000},{"time":"2017-12-30","value":3727264000},{"time":"2018-12-30","value":3476946000},{"time":"2019-12-30","value":3489628000},{"time":"2020-12-30","value":3587874000},{"time":"2021-12-30","value":4661433000},{"time":"2022-12-30","value":3449801000}],"ROE":[{"time":"2014-12-30","value":0.11042242614641735},{"time":"2015-12-30","value":0.0515080962833128},{"time":"2016-12-30","value":0.04141505115499602},{"time":"2017-12-30","value":-0.019573875099805113},{"time":"2018-12-30","value":0.04032159257003129},{"time":"2019-12-30","value":-0.15120408249819178},{"time":"2020-12-30","value":0.011880294569987687},{"time":"2021-12-30","value":0.015372311475891642},{"time":"2022-12-30","value":-0.00385297586730365}],"ROA":[{"time":"2014-12-30","value":0.056528289886486005},{"time":"2015-12-30","value":0.04227661137762091},{"time":"2016-12-30","value":0.0372745326530168},{"time":"2017-12-30","value":0.004344607513573266},{"time":"2018-12-30","value":0.03587940529434853},{"time":"2019-12-30","value":0.0275641844839574},{"time":"2020-12-30","value":0.022075755735287896},{"time":"2021-12-30","value":0.030138884566626483},{"time":"2022-12-30","value":-0.0004841750350084994}]}

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufacture and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Sector

  • ALGN Logo

    ALGN

  • AVNS Logo

    AVNS

  • CDRE Logo

    CDRE

  • ESTA Logo

    ESTA

  • EW Logo

    EW

  • ISRG Logo

    ISRG

  • MSA Logo

    MSA

In the chart Earnings are multiplied by this value.

Earnings Growth -16%
Earnings Stability 12%


Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12-201412-201512-201612-201712-201812-201912-202012-202112-2022TTM
Net Margin8%4.2%3.5%-2.2%3.8%-16%1.4%1.9%-0.85%-4.5%
ROA5.7%4.2%3.7%0.43%3.6%2.8%2.2%3%-0.048%-1.4%
ROE11%5.2%4.1%-2%4%-15%1.2%1.5%-0.39%-2.2%

What is the average Net Margin?

The average Net Margin over the past 5 years is -1.97%.

What is the trend of Net Margin?

The trend of Net Margin over the past 5 years is +0.52%.

What is the average Return on Assets (ROA)?

The average ROA over the past 5 years is +1.99%.

What is the trend of Return on Assets (ROA)?

The trend of ROA over the past 5 years is -0.13%.

What is the average Return on Equity (ROE)?

The average ROE over the past 5 years is -1.78%.

What is the trend of Return on Equity (ROE)?

The trend of ROE over the past 5 years is +0.48%.


Safety & Stabiliy

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12-201412-201512-201612-201712-201812-201912-202012-202112-2022TTM
Debt FCF-6.127.107.177.73425.0212.158.35-2.97-3.93
Debt Equity0.470.440.420.290.350.680.630.450.140.11
MIN
Graham Stability----33%100%-810%----810%

What is the Debt/FCF?

The Debt/FCF trailing twelve month is -3.93.

What is the trend of Debt/FCF?

The trend of Debt/FCF over the past 5 years is -13.19.

What is the Graham’s Stability?

Graham’s Stability measure stands at -8.10.


Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12-201512-201712-201912-2021Trend
Revenue-12%-14%-22%-59%-1.9%
Net Income----20%
Stockholders Equity0.83%-1.5%-0.38%-26%-0.4%
FCF----240%

What is the 5 year Revenue CAGR?

The Revenue CAGR over the past 5 years is -13.88%.

What is the trend of Revenue growth?

The trend of Revenue growth rate over the past 5 years is -1.95%.

What is the 5 year Earnings CAGR?

The Earnings CAGR over the past 5 years is -28.86%.

What is the trend of Earnings growth?

The trend of Earnings growth rate over the past 5 years is +19.78%.

What is the 5 year Equity CAGR?

The Equity CAGR over the past 5 years is -1.54%.

What is the trend of Equity growth?

The trend of Equity growth rate over the past 5 years is -0.4%.

What is the 5 year FCF CAGR?

The FCF CAGR over the past 5 years is -.

What is the trend of FCF growth?

The trend of FCF growth rate over the past 5 years is +238.74%.